Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliers
advertisement
advertisement
advertisement
advertisement
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
Validation of Water Systems for Microbial Control
-
Introducing LabAiQ: Next Generation Reporting that Elevates Industry Standards
-
Bring Your Pipetting Results to the Next Level
-
USP Chapter <86> and the Move to Recombinant Methods
-
2025 Novogene Sequencing Symposium
-
Explore the Future of Sterility Testing with Rapid Micro Biosystems®
-
Understanding USP <73> to Accelerate Sterility Testing for Short-Life Products
-
British Society For Microbial Technology 40th Anniversary Microbiology Conference
-
How Is VIDAS® KUBE™ Transforming Food Pathogen Detection?
-
Sampling and Microbial Testing of Water and Data Trending
